Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patron
    • Parent Involvement Forum
    • Join our Team
    • Annual reports
  • About neuroblastoma
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Neuroblastoma treatment
  • Support
    • Family support
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2020
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Funding award process
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Support Our Work
    • Donate now
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)
  • Research

Research

We're fighting for a future where no child dies of neuroblastoma or suffers due to its treatment.

But this will not happen without clinical research, something we are actively initiating and funding.

We are committed to working with experts worldwide to proactively drive forward the development of more, better and less toxic treatment options, bringing them to the UK and Ireland for children fighting neuroblastoma now. Through this, we are determined to advance science and find a cure for future generations.

Our Research Strategy

At Solving Kids’ Cancer, we focus on clinical trials, research that is designed to find out whether a new experimental therapy is better than the current way of treating children. If it is, it can become standard care, helping more children and not just those on the trial.
 

 
Our research mission is to bring more effective and less harmful treatments into the clinic to benefit children. Despite intensive therapy, too few children are cured, and many that are suffer lifelong health problems. For this reason, we are actively pursuing the identification of groups of patients who might benefit from novel therapies earlier in the course of their disease.
 
We are working to impact frontline treatment – driving innovation and discovery of new treatment strategies – so that children are treated more effectively from diagnosis and experience less severe acute and long-term toxicities. For relapsed and refractory children every trial we fund is another option bringing hope to families, closer to home.
 
We have also established the Solving Kids' Cancer Senior Trials Coordinator at the University of Birmingham, a new role responsible for all neuroblastoma trials in the UK.
 
Read our Research Strategy

High-quality medical research

Our Scientific Advisory Board comprises of seven leading experts in childhood cancer. They help to guide our work.

We are also AMRC accredited, full membership that recognises the charity as funders of high quality and credible medical research. 

Being an AMRC member means the Department of Health meets all costs for local trial coordination and management, data collection and regulatory fees in NHS hospitals that open clinical trials we fund. It also means up to 20p of government money is added to every £1 we spend on academic research, making every penny we spend on research go as far as it possibly can.

 
AMRC Logo

Collaborating in partnership

We work with experts and like-minded charities around the world to do all we can for children affected by neuroblastoma because we believe that national and international collaboration speeds up the pace of research and pooling resources achieves more.

We aim to play a leading role in increasing, shaping, and accelerating neuroblastoma research in the UK, bringing insight from those impacted by neuroblastoma and working in partnership with others. Find out more about our funding partners and collaborative work.

Parent-led research advocacy

We don’t just initiate and fund research. We are a voice for children and their families and put that right at the heart of our research funding.
 
We identify unmet needs and challenge experts to work with us to address them through research. We use our influence and reputation as passionate advocates to help shape and steer research so that it puts children first - a concept known as Research Advocacy.
 

Published: 7th May, 2019

Updated: 21st October, 2019

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Karen and Evie’s 23 day Squatty Botty

    Karen and Evie’s 23 day Squatty Botty

    We are taking on the Squatty Botty challenge to raise much needed funds for dear little Ollie

  • Leeanne Brennan

  • A Half Marathon for Henry The Brave

    A Half Marathon for Henry The Brave

    Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family need support for his on going treatment.

  • Naomi Bentham

Most read

  • Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

  • Corey is thriving after neuroblastoma battle

    Corey is thriving after neuroblastoma battle

    Family donate almost £150,000 to neuroblastoma research

  • Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.

  • BEACON study opens in Europe

    BEACON study opens in Europe

    The much-anticipated BEACON study amendment is now open and recruiting patients.

  • Steve Richards to step down as Chief Executive

    Steve Richards to step down as Chief Executive

    CEO to leave Solving Kids' Cancer after three years in the role.

  • Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

  • Charities fund new clinical trial

    Charities fund new clinical trial

    Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

  • First Three Months

    First Three Months

    Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.

  • Henry's Urgent Appeal

    Henry's Urgent Appeal

    Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family are appealing for your help to raise £163,000 by January 2021.

  • Ewen's Journey

    Ewen's Journey

    Ewen sadly passed away on 28th September 2020.

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.